Skip to main content
. 2021 Feb 11;11:563085. doi: 10.3389/fcimb.2021.563085

Figure 2.

Figure 2

Blocking SARS coronavirus2 (SARS–CoV2) cell entry. SARS-CoV-2 binds to ACE2 and then uses the transmembrane Serine Protease 2 (TMPRSS2) for S protein priming and entry to cell. A TMPRSS2 inhibitor can blocked viral entry by binding to and inhibition of enzyme activity.